The detection of minimal residual disease (MRD) during the first phase of treatment can predict outcome in childhood acute lymphoblastic leukemia (ALL). 1 Currently MRD detection in ALL patients provides important information in order to assign a tailored-treatment and the risk of an impending relapse. Nevertheless, the major treatment failure in ALL occurs predominantly in patients with T-cell ALL. This reflects especially a more therapy-resistance and a slower clearance of blasts of T-ALL in comparison with precursor-B-ALL. 2 Therefore, the quantification of early response to therapy and the monitoring of MRD during and after treatment can greatly improve the outcome and long-term quality of life of these patients. In childhood ALL, detection of MRD with high sensitivity (ie 10
À4
, 10
À5
) can be achieved by quantitative PCR methods (RQ-PCR) of rearranged immunoglobulin (Ig) and T-cell receptor (TCR) genes. 1, 3 The usefulness of these specific PCR targets should give attention to the possible modification of Ig and TCR gene rearrangements that could occur during the course of disease, due to continue activity of the V(D)J recombinase enzymes in leukemic blasts. 1 The stability of Ig and TCR gene rearrangements between diagnosis and relapse has been reported in several studies, especially in precursor-B-ALL 4-6 but only few works focused insight clonal phenomena in relapses of T-ALL. Therefore, to understand how this mechanism can influence the MRD assays in children with T-ALL, we analyzed by extensive sequence analysis 32 diagnostic leukemic samples from patients (aged: 2.3-18.1 years) with first bone marrow (BM) relapse enrolled between 1993 and 2002 into AIEOP-BFM Study Group protocols. We compared the V-(D)-J joining sequences between diagnosis and relapse of TCRG, TCRD, TCRB, TAL1 and incomplete DJH gene rearrangements currently used for MRD monitoring in T-ALL. The diagnosis of T-ALL was based by use of cytomorphology and flowcytometric immunophenotyping criteria. 7 Mononuclear cells were isolated from BM by FicollPaque centrifugation, and the DNA was extracted and purified according to the manufacturer's instructions using Gentra kit (Gentra System, Minneapolis, MN, USA). PCR analysis of TCRG, TCRD and DJH gene rearrangements was independently performed on diagnosis and relapse samples, as published elsewhere. 8 For the amplification of TCRB complete (Vb-Jb) rearrangements, a two-step seminested PCR approach was applied as described by Willenbrock et al. 9 For incomplete TCRB gene rearrangements we designed two specific Db primers (Db1 5 0 -ACAGCCTTACAAAGACATCCAGC-3 0 , Db2 5 0 -TTTGTCTTTTCCAAGCCCCA-3 0 , GenBank accession no. NG001333) and used the same conditions as for the amplification of complete Vb-Jb rearrangements. 9 All clonal gene rearrangements identified by heteroduplex or GeneScan analyses 6, 8 were sequenced by dye-terminator cycle sequencing kit on ABI Prism 310 (Applied Biosystems, Foster City, CA, USA). TCR and DJH gene segments were identified in comparison with published sequences using NCBI database nucleotide-nucleotide BLAST (http://www.ncbi.nlm.nih.gov/blast/) and IGMT/ junctionAnalysis database (http://imgt.cines.fr/textes/vquest/). We found at least one or several clonal DJH and/or TCR gene rearrangements in all patients at diagnosis (TCRG 81, TCRD 41, TCRB 91 and DJH 25%). At relapse 91% (29/32) of patients conserved at least one of the original gene rearrangements: TCRG 92, TCRD 92, TCRB 86 and DJH 88%, respectively (Table 1 ). In 20 of the 32 (63%) patients the original sequences were fully conserved at relapse. Conversely only in two patients (cases #11t, and #21t) all clonal PCR targets at relapse were lost ( Figure 1 ). In all 103 out of 121 (85%) clonal V-(D)-J sequences identified in diagnostic samples were preserved identical at relapse: 39 out of 44 (89%) TCRG, 15 out of 16 (94%) TCRD, 38 out of 49 (77%) TCRB and 8 out of 9 (89%) DJH rearrangements. SIL/TAL1 fusion gene detected in only three patients (9%) at diagnosis was found with identical breakpoint sequences at relapse. Clonal evolution phenomena have been identified in 37% (12/32) of patients. In 11 cases there was loss of clonal PCR targets at relapse: three TCRG, one TCRD, eight TCRB and two DJH clonal rearrangements respectively (Figure 1) . We found the occurrence of secondary and ongoing rearrangements in three patients (cases #8t, #22t and #17t) regarding the TCRB locus. In one patient (case #22t) the comparative sequence analysis of Vb-D-Jb junction showed a very distinct N region at diagnosis and relapse maintaining a common Db-Jb that confirmed pre-existing D-J rearrangement from original transformed progenitor cell. This suggests a mechanism of ongoing recombination occurring during outgrowth of leukemic clone. On the contrary, in the other two patients the changes at both Vb-Jb (case #8t) and Db-Jb (case #17t) join junctions at relapse were unrelated with the diagnostic sequences, suggesting that the clones may have undergone de novo rearrangements during outgrowth. Nevertheless, the relationship between diagnosis and relapse for these patients (cases #8t, #22t and #17t) was maintained by conserved TCRG and/or other TCRB gene rearrangements (Figure 1) . Finally, there were six patients that relapsed with new clonal PCR targets (four TCRG, four TCRD, three TCRB and one DJH gene rearrangements), which could not be detected at diagnosis even by RQ-PCR using specific primers designed from the relapse sequences (data not shown). In agreement with the observation of Szczepanski et al, 10 we found that the overall stability of clonal rearrangements in T-ALL was significantly higher compared with precursor-B-ALL. Specifically, 83% of original clonal sequences identified at diagnosis were conserved at relapse, compared to 71% found in our previous study on precursor-B-ALL patients. 6 Furthermore, the proportion of patients with all clonal PCR targets conserved at relapse was significantly higher in T-ALL (63%) in comparison with precursor-B-ALL (43%). 6 Moreover, our data suggest that TCRB gene rearrangements are more prone to undergo clonal evolution phenomena as compared to TCRG, TCRD and incomplete DJH rearrangements. In fact, in nine patients (28%) original clonal TCRB rearrangements at relapse were found lost and/or changed compared to 15% (5/32) for TCRG, 3% (1/32) for TCRD and 3% (1/32) of patients for DJH gene rearrangements (Figure 1) . Besides, our data were comparable with those previously published for childhood T-ALL using the BIOMED-2 multiplex TCRB PCR assay, 11 confirming the reliability of our findings. Nevertheless, some discrepancies concerning the frequency of complete Vb-Jb and incomplete Db-Jb gene rearrangements found at diagnosis (72 and 52%, respectively) could be due to the different primer set utilized for detection of clonal TCRB rearrangements.
In conclusion, our extensive sequence analysis of DJH/TCR patterns at diagnosis and relapse in childhood T-ALL shows that TCRB gene rearrangements are relatively unstable. It should be noted, however, that recent findings indicate that TCRB gene rearrangements represent a suitable RQ-PCR target for MRD detection 11 in T-ALL. For this reason we recommend that TCRB target should be used in combination with another different available clonal PCR target (DJH and/or TCRG and/or TCRD) to prevent false negative results in MRD monitoring. 
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